Literature DB >> 13763330

Ganglionic actions of neostigmine methylsulfate.

J P LONG, J W ECKSTEIN.   

Abstract

Entities:  

Keywords:  NEOSTIGMINE/pharmacology

Mesh：

Substances：

Year:  1961        PMID： 13763330

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN： 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  8 in total

1.  An analysis of the autonomic control of gastrointestinal motility in the cat.

Authors:  J Neely; B N Catchpole
Journal:  Gut       Date:  1967-06       Impact factor: 23.059

2.  Release of 5-hydroxytryptamine from isolated dog intestine by nicotine.

Authors:  T F Burks; J P Long
Journal:  Br J Pharmacol Chemother       Date:  1967-06

3.  Different properties of the bradycardia produced by neostigmine and edrophonium in the cat.

Authors:  S B Backman; R D Stein; D W Blank; B Collier; C Polosa
Journal:  Can J Anaesth       Date:  1996-07       Impact factor: 5.063

4.  Central acetylcholinesterase inhibition improves hemodynamic counterregulation to severe blood loss in alcohol-intoxicated rats.

Authors:  Keisa W Mathis; Patricia E Molina
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-06-10       Impact factor: 3.619

5.  Asynchronous postganglionic firing from the cat superior cervical sympathetic ganglion treated with neostigmine.

Authors:  C TAKESHIGE; R L VOLLE
Journal:  Br J Pharmacol Chemother       Date:  1963-02

6.  THE EFFECTS OF NEOSTIGMINE UPON GANGLION RESPONSES AFTER ADMINISTRATION OF BLOCKING DRUGS.

Authors:  P A FENNER; J G HILTON
Journal:  Br J Pharmacol Chemother       Date:  1963-10

7.  THE MODE OF ACTION OF NEOSTIGMINE AND PHYSOSTIGMINE ON THE GUINEA-PIG TRACHEALIS MUSCLE.

Authors:  R F CARLYLE
Journal:  Br J Pharmacol Chemother       Date:  1963-08

8.  Autonomic and cholinergic mechanisms mediating cardiovascular and temperature effects of donepezil in conscious mice.

Authors:  Aaron J Polichnowski; Geoffrey A Williamson; Tesha E Blair; Donald B Hoover
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2021-04-14       Impact factor: 3.210
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.